Alcon bought Aerie Pharmaceuticals Aerie Pharmaceuticals from 11/22/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Alcon completed its acquisition of Aerie Pharmaceuticals for $770 million, or 15.25 per share.

Aerie Pharmaceuticals

Review

Source:

{source} pictogram

investor.alcon.com

Vladimir Petenev

News editor

Write your comment first

News feed

Pharmsintez reported for 3 months of 2024 by RAS

5/7/24 LIFE

KGC reported for 3 months of 2024 by RAS

5/7/24 KGKC

Globaltrak reported for the 3 months of 2024 by RAS

5/7/24 GTRK

RSC Energia reported for 2023 by IFRS

5/7/24 RKKE

Novabev Group reported for 3 months of 2024 by RAS

5/7/24 BELU

Ingrad reported for the 3 months of 2023 by RAS

5/7/24 INGR

Seligdar started installation of process equipment at Hvoynoye

5/7/24 SELG

Lenenergo may buy LOESK

5/7/24 LSNG

Lenenergo reported for 3 months of 2024 by RAS

5/6/24 LSNG

Levenguc reported for 2023 by IFRS

5/6/24 LVHK